Sophie M. Bilik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sophie M. Bilik has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Irena Pastar
Wound Healing and Regenerative Medicine Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami Florida USA
3 shared publications - Olivia Marie Burke
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, USA
3 shared publications - Rivka C. Stone
Wound Healing and Regenerative Medicine Research Program, Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA
3 shared publications Garrett P. Kraft
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery University of Miami Miller School of Medicine Miami Florida USA
2 shared publications- Tammy Gonzalez
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
2 shared publications - Alexia Vignau
University of Miami
1 shared publication
Latest Publications
- Open Access
- 10 November 2026
- Published by Springer Nature in American Journal of Clinical Dermatology
Hidradenitis Suppurativa in Transgender and Gender Diverse Populations: Bridging Gaps in Care and Knowledge
- 10 November 2026
- Published by Springer Nature in American Journal of Clinical Dermatology
Open AccessHidradenitis Suppurativa in Transgender and Gender Diverse Populations: Bridging Gaps in Care and Knowledge
- Open Access
- 30 September 2026
- Published by Wiley in JEADV Clinical Practice
Cutaneous Angiosarcoma Survival by Anatomic Site and Race/Ethnicity: A Dual Cohort Analysis
Background: Cutaneous angiosarcoma (cAS) is a rare and aggressive vascular malignancy associated with poor survival. Large‐scale evaluations of prognostic factors, particularly anatomic site and race/ethnicity, remain limited. Objectives: To evaluate survival outcomes in cAS according to anatomic site and race/ethnicity using complementary national datasets. Methods: We conducted a dual‐cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database (2000–2023) and the All of Us Research Program (2018–2025). Patients with histologically confirmed cAS were identified and categorised by anatomic site. Kaplan–Meier analyses and multivariable Cox proportional hazards models adjusted for age, sex, and available clinical factors were performed. Results: Across both cohorts, survival differed significantly by anatomic site, with head and neck tumours demonstrating the poorest outcomes. In SEER, head and neck lesions were associated with increased mortality compared with trunk tumours (HR 1.85, 95% CI 1.65–2.08), while upper extremity tumours demonstrated improved survival (HR 0.75, 95% CI 0.62–0.90). Similar patterns were observed in All of Us. Racial and ethnic disparities were also identified. In SEER, non‐Hispanic Black patients (HR 1.42, 95% CI 1.20–1.69) and Hispanic patients (HR 1.31, 95% CI 1.12–1.53) experienced worse survival compared with non‐Hispanic White patients. Limitations: This study is limited by potential residual confounding, differences in covariates available between datasets, limited statistical power in the All of Us cohort, and lack of pathology confirmation by sarcoma specialists. Conclusions: In this dual‐cohort analysis, anatomic site and race/ethnicity were independently associated with survival in cAS. Consistent findings across SEER and All of Us highlight persistent disparities in outcomes and the need for improved risk stratification, earlier diagnosis, and equitable access to specialised care.
- 30 September 2026
- Published by Wiley in JEADV Clinical Practice
Open AccessCutaneous Angiosarcoma Survival by Anatomic Site and Race/Ethnicity: A Dual Cohort Analysis
Background: Cutaneous angiosarcoma (cAS) is a rare and aggressive vascular malignancy associated with poor survival. Large‐scale evaluations of prognostic factors, particularly anatomic site and race/ethnicity, remain limited. Objectives: To evaluate survival outcomes in cAS according to anatomic site and race/ethnicity using complementary national datasets. Methods: We conducted a dual‐cohort analysis using the Surveillance, Epidemiology, and End Results (SEER) database (2000–2023) and the All of Us Research Program (2018–2025). Patients with histologically confirmed cAS were identified and categorised by anatomic site. Kaplan–Meier analyses and multivariable Cox proportional hazards models adjusted for age, sex, and available clinical factors were performed. Results: Across both cohorts, survival differed significantly by anatomic site, with head and neck tumours demonstrating the poorest outcomes. In SEER, head and neck lesions were associated with increased mortality compared with trunk tumours (HR 1.85, 95% CI 1.65–2.08), while upper extremity tumours demonstrated improved survival (HR 0.75, 95% CI 0.62–0.90). Similar patterns were observed in All of Us. Racial and ethnic disparities were also identified. In SEER, non‐Hispanic Black patients (HR 1.42, 95% CI 1.20–1.69) and Hispanic patients (HR 1.31, 95% CI 1.12–1.53) experienced worse survival compared with non‐Hispanic White patients. Limitations: This study is limited by potential residual confounding, differences in covariates available between datasets, limited statistical power in the All of Us cohort, and lack of pathology confirmation by sarcoma specialists. Conclusions: In this dual‐cohort analysis, anatomic site and race/ethnicity were independently associated with survival in cAS. Consistent findings across SEER and All of Us highlight persistent disparities in outcomes and the need for improved risk stratification, earlier diagnosis, and equitable access to specialised care.
- Open Access
- 26 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1915200
Epigenetic reprogramming in autoimmune and immune-mediated skin disease
Background: Autoimmune skin diseases exhibit chronicity and site-specific relapse that are not fully explained by genetic susceptibility or cytokine signaling alone. Emerging evidence suggests that epigenetic reprogramming of skin-resident immune cells contributes to disease persistence and recurrence. Methods: We conducted a structured narrative review of the human literature by searching PubMed for studies published from database inception through March 1, 2026. The literature search was performed between February 1 and March 1, 2026 and focused on epigenetic mechanisms across major autoimmune dermatoses, including DNA methylation, histone modification, chromatin accessibility, non-coding RNA regulation, and emerging single-cell and spatial epigenomic technologies. Results: Current evidence suggests stable chromatin remodeling in keratinocytes and immune cells, including tissue-resident memory T cells, that persists after clinical resolution and may facilitate rapid disease reactivation. Environmental exposures further reinforce these epigenetic programs, contributing to disease heterogeneity, chronicity, and site-specific relapse. Conclusion: Collectively, these findings are consistent with a model in which autoimmune skin diseases are maintained by maladaptive epigenetic memory. Although causal inference remains limited by the relative scarcity of cell-type–resolved human epigenomic data and the predominance of cross-sectional studies, this framework suggests that achieving durable therapeutic remission may require reprogramming pathogenic chromatin states rather than solely suppressing inflammatory pathways.
- 26 August 2026
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1915200
Open AccessEpigenetic reprogramming in autoimmune and immune-mediated skin disease
Background: Autoimmune skin diseases exhibit chronicity and site-specific relapse that are not fully explained by genetic susceptibility or cytokine signaling alone. Emerging evidence suggests that epigenetic reprogramming of skin-resident immune cells contributes to disease persistence and recurrence. Methods: We conducted a structured narrative review of the human literature by searching PubMed for studies published from database inception through March 1, 2026. The literature search was performed between February 1 and March 1, 2026 and focused on epigenetic mechanisms across major autoimmune dermatoses, including DNA methylation, histone modification, chromatin accessibility, non-coding RNA regulation, and emerging single-cell and spatial epigenomic technologies. Results: Current evidence suggests stable chromatin remodeling in keratinocytes and immune cells, including tissue-resident memory T cells, that persists after clinical resolution and may facilitate rapid disease reactivation. Environmental exposures further reinforce these epigenetic programs, contributing to disease heterogeneity, chronicity, and site-specific relapse. Conclusion: Collectively, these findings are consistent with a model in which autoimmune skin diseases are maintained by maladaptive epigenetic memory. Although causal inference remains limited by the relative scarcity of cell-type–resolved human epigenomic data and the predominance of cross-sectional studies, this framework suggests that achieving durable therapeutic remission may require reprogramming pathogenic chromatin states rather than solely suppressing inflammatory pathways.
- Open Access
- 15 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3820
A Neuroendocrine–Immune Model of Hidradenitis Suppurativa: Mechanistic Insights into Pain, Pruritus, and Hormonal Triggers
Background/Objectives: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease traditionally viewed through a purely dermatologic lens. However, this perspective fails to explain stress-induced flares, menstrual cycle-linked exacerbations, and severe pain and itch disproportionate to visible cutaneous inflammation. This narrative review synthesizes evidence supporting a neuroendocrine–immune model of HS pathogenesis, with emphasis on mechanisms underlying pain and itch. Methods: A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases (January 1990–September 2025) with terms including hidradenitis suppurativa, neuroendocrine mechanisms, HPA axis, sex hormones, neuropeptides, pain (including nociceptive and neuropathic pain, burning, and dysesthesia), and pruritus (itch). Eligible studies included peer-reviewed research examining hormonal, stress-related, or neuropeptide mechanisms in HS. Data were synthesized into thematic categories: endocrine influences, HPA axis function, neuropeptide signaling, immune crosstalk, and clinical implications. Results: Sex hormones promote follicular occlusion and modulate immune responses, explaining perimenstrual flares. Prolactin amplifies inflammation during stress through immune cell activation. Insulin resistance and adipokine imbalance create pro-inflammatory conditions. Chronic stress induces HPA axis dysfunction with cortisol resistance, exacerbating inflammation. Neuropeptides released from cutaneous nerves amplify immune activation and directly mediate pain and itch. These pathways establish self-perpetuating feedback loops wherein inflammation drives stress, and neuroendocrine dysfunction amplifies immune responses. Conclusions: HS represents a systemic disorder with a strong neuroendocrine–immune component, rather than a purely dermatologic condition. This framework supports multidisciplinary management integrating hormonal therapies, targeted immunomodulation, and stress reduction. Future research should characterize neuroendocrine biomarkers and test combination therapies targeting multiple system nodes.
- 15 May 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (10) , 3820
Open AccessA Neuroendocrine–Immune Model of Hidradenitis Suppurativa: Mechanistic Insights into Pain, Pruritus, and Hormonal Triggers
Background/Objectives: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease traditionally viewed through a purely dermatologic lens. However, this perspective fails to explain stress-induced flares, menstrual cycle-linked exacerbations, and severe pain and itch disproportionate to visible cutaneous inflammation. This narrative review synthesizes evidence supporting a neuroendocrine–immune model of HS pathogenesis, with emphasis on mechanisms underlying pain and itch. Methods: A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases (January 1990–September 2025) with terms including hidradenitis suppurativa, neuroendocrine mechanisms, HPA axis, sex hormones, neuropeptides, pain (including nociceptive and neuropathic pain, burning, and dysesthesia), and pruritus (itch). Eligible studies included peer-reviewed research examining hormonal, stress-related, or neuropeptide mechanisms in HS. Data were synthesized into thematic categories: endocrine influences, HPA axis function, neuropeptide signaling, immune crosstalk, and clinical implications. Results: Sex hormones promote follicular occlusion and modulate immune responses, explaining perimenstrual flares. Prolactin amplifies inflammation during stress through immune cell activation. Insulin resistance and adipokine imbalance create pro-inflammatory conditions. Chronic stress induces HPA axis dysfunction with cortisol resistance, exacerbating inflammation. Neuropeptides released from cutaneous nerves amplify immune activation and directly mediate pain and itch. These pathways establish self-perpetuating feedback loops wherein inflammation drives stress, and neuroendocrine dysfunction amplifies immune responses. Conclusions: HS represents a systemic disorder with a strong neuroendocrine–immune component, rather than a purely dermatologic condition. This framework supports multidisciplinary management integrating hormonal therapies, targeted immunomodulation, and stress reduction. Future research should characterize neuroendocrine biomarkers and test combination therapies targeting multiple system nodes.
- 18 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Merkel cell carcinoma in transplant recipients: Clinical and geographic insights
- 18 November 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (6)
Merkel cell carcinoma in transplant recipients: Clinical and geographic insights
- Open Access
Multi-omics identification of activated T cells and spatial PD-1/PD-L1 signaling as biomarkers of diabetic foot ulcer healing
Diabetic foot ulcers (DFUs) are a common and debilitating complication of diabetes, and amputations from non-healing ulcers carry high morbidity and mortality. A critical need exists for biomarkers that can identify healing potential early and guide targeted interventions. To address this, we applied an integrated multi-omics approach across four patient cohorts comprising 51 DFUs (29 Healing, 22 Non-healing). Bulk RNA-sequencing revealed marked activation of Th1 and Th2 pathways (activation z-score +4.8, p = 3.8×10⁻¹⁵), and immune cell deconvolution predicted higher proportions of T cell populations in Healers. Spatial proteomics in a second cohort identified elevated CD3⁺ T cell density and selective enrichment of PD-1 and PD-L1 expression in vascular niches of the papillary dermis in Healers (p < 0.001). Flow cytometry in a third cohort further demonstrated higher proportions of CD3⁺PD-1⁺ and CD3⁺PD-L1⁺ T cells in Healers compared with Non-healers. Single-cell RNA-sequencing from a fourth cohort showed upregulation of PD-1 and PD-L1 within CD4⁺ T cells from Healers. Complementary immunofluorescence and serological profiling confirmed that both PD-1 and PD-L1 are elevated in tissue and circulating serum of healing DFUs, supporting their potential use as systemic biomarkers. Taken together, vascular-enriched PD-1/PD-L1 signaling and T cell activation were observed in association with healing DFUs, supporting PD-1/PD-L1 as candidate biomarkers in both tissue and blood with potential translational relevance for predicting DFU outcomes and informing precision therapies.
Open AccessMulti-omics identification of activated T cells and spatial PD-1/PD-L1 signaling as biomarkers of diabetic foot ulcer healing
Diabetic foot ulcers (DFUs) are a common and debilitating complication of diabetes, and amputations from non-healing ulcers carry high morbidity and mortality. A critical need exists for biomarkers that can identify healing potential early and guide targeted interventions. To address this, we applied an integrated multi-omics approach across four patient cohorts comprising 51 DFUs (29 Healing, 22 Non-healing). Bulk RNA-sequencing revealed marked activation of Th1 and Th2 pathways (activation z-score +4.8, p = 3.8×10⁻¹⁵), and immune cell deconvolution predicted higher proportions of T cell populations in Healers. Spatial proteomics in a second cohort identified elevated CD3⁺ T cell density and selective enrichment of PD-1 and PD-L1 expression in vascular niches of the papillary dermis in Healers (p < 0.001). Flow cytometry in a third cohort further demonstrated higher proportions of CD3⁺PD-1⁺ and CD3⁺PD-L1⁺ T cells in Healers compared with Non-healers. Single-cell RNA-sequencing from a fourth cohort showed upregulation of PD-1 and PD-L1 within CD4⁺ T cells from Healers. Complementary immunofluorescence and serological profiling confirmed that both PD-1 and PD-L1 are elevated in tissue and circulating serum of healing DFUs, supporting their potential use as systemic biomarkers. Taken together, vascular-enriched PD-1/PD-L1 signaling and T cell activation were observed in association with healing DFUs, supporting PD-1/PD-L1 as candidate biomarkers in both tissue and blood with potential translational relevance for predicting DFU outcomes and informing precision therapies.
- Open Access
- 1 November 2025
- Published by Wiley in Wound Repair and Regeneration
- Vol. 33 (6) , e70119
Prospective Evaluation of Thermographic Imaging for Early Detection of Pressure Injuries: A Follow‐Up Study
Pressure injuries are a major source of morbidity in critically ill patients, and early recognition is particularly difficult in patients with darker skin tones where erythema may be missed. This prospective study evaluated thermographic imaging with the Wound Scout in 32 patients (40 wound encounters) admitted to the ICU. Abnormal temperature, defined as > ±1.1°C, was significantly associated with deep tissue pressure injury (DTPI) diagnosis, with an odds ratio of 6.1 (95% CI 1.2–36.6), sensitivity of 83% and positive predictive value of 74%. Wound Scout changed the diagnosis in 25% of encounters, most often in sacral wounds where visual inspection is limited. Performance was consistent across Fitzpatrick skin types, supporting its utility in skin of colour. Longitudinal data from a small subset ( n = 10) did not show predictive value for progression. Thermography offers an objective, equitable adjunct to clinical assessment that may improve early detection of pressure injuries.
- 1 November 2025
- Published by Wiley in Wound Repair and Regeneration
- Vol. 33 (6) , e70119
Open AccessProspective Evaluation of Thermographic Imaging for Early Detection of Pressure Injuries: A Follow‐Up Study
Pressure injuries are a major source of morbidity in critically ill patients, and early recognition is particularly difficult in patients with darker skin tones where erythema may be missed. This prospective study evaluated thermographic imaging with the Wound Scout in 32 patients (40 wound encounters) admitted to the ICU. Abnormal temperature, defined as > ±1.1°C, was significantly associated with deep tissue pressure injury (DTPI) diagnosis, with an odds ratio of 6.1 (95% CI 1.2–36.6), sensitivity of 83% and positive predictive value of 74%. Wound Scout changed the diagnosis in 25% of encounters, most often in sacral wounds where visual inspection is limited. Performance was consistent across Fitzpatrick skin types, supporting its utility in skin of colour. Longitudinal data from a small subset ( n = 10) did not show predictive value for progression. Thermography offers an objective, equitable adjunct to clinical assessment that may improve early detection of pressure injuries.
- 30 September 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Geospatial and demographic patterns of dermatomyositis in a diverse US national cohort
- 30 September 2025
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 40 (2)
Geospatial and demographic patterns of dermatomyositis in a diverse US national cohort
- 21 August 2025
- Published by Springer Nature
- p. 97-114
Racket Sports and Volleyball
- Open Access
- 9 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5633
Host–Microbiome Interactions in Chronic Itch
Chronic itch is a debilitating condition characterized by persistent pruritus lasting more than six weeks, significantly impairing quality of life. While the role of the immune system and neural circuits in itch is increasingly understood, the contribution of the skin microbiome, especially in non-atopic itch disorders, remains underexplored. This review synthesizes emerging evidence on how microbial dysbiosis contributes to chronic pruritus through multiple molecular pathways: disruption of skin barrier integrity, modulation of neuroimmune signaling axes, and direct activation of pruriceptors. We highlight recent studies identifying microbiome shifts in prurigo nodularis (PN) and lichen simplex chronicus (LSC), independent of atopic dermatitis (AD). We also evaluate advances in biologics and small-molecule therapeutics, exploring how targeted immune modulation may restore microbial balance and alleviate neuroinflammation. A systems biology approach integrating microbial genomics, neurobiology, and host immunity is critical to unraveling the complex interplay between host and microbes in chronic itch, particularly in understudied non-atopic conditions that disproportionately affect vulnerable populations.
- 9 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5633
Open AccessHost–Microbiome Interactions in Chronic Itch
Chronic itch is a debilitating condition characterized by persistent pruritus lasting more than six weeks, significantly impairing quality of life. While the role of the immune system and neural circuits in itch is increasingly understood, the contribution of the skin microbiome, especially in non-atopic itch disorders, remains underexplored. This review synthesizes emerging evidence on how microbial dysbiosis contributes to chronic pruritus through multiple molecular pathways: disruption of skin barrier integrity, modulation of neuroimmune signaling axes, and direct activation of pruriceptors. We highlight recent studies identifying microbiome shifts in prurigo nodularis (PN) and lichen simplex chronicus (LSC), independent of atopic dermatitis (AD). We also evaluate advances in biologics and small-molecule therapeutics, exploring how targeted immune modulation may restore microbial balance and alleviate neuroinflammation. A systems biology approach integrating microbial genomics, neurobiology, and host immunity is critical to unraveling the complex interplay between host and microbes in chronic itch, particularly in understudied non-atopic conditions that disproportionately affect vulnerable populations.